TE_172

Basic information Differential Expression Stage analysis Survival analysis Correlation analysis

TE family L2
TE superfamily L2
TE class LINE
Gene -
Class Intergenic
Coding Non-coding, Other
Tumor-specific score 22.54
Counts of samples TCGA_tumor:79; TCGA_normal:0; GTEx:3
TSS chr1(-):17377419



Transcript isoforms

Transcript_ID Gene Class Coding ORF Position
teRNA_172.1 - Intergenic Non-coding Non-coding chr1(-):17371035,17371055,17373044,17373368,17377281,17377420
teRNA_172.2 - Intergenic Other MRSDVQNNVFPRLESRLQPGGSPSGCARSHPGRCPSPLPLRLTLSASTEGLGDVIFTVAYVGSDRGHQMVASSFSEITVLATSIKTLPEPWMVKHWHFWGAHLVCPRQSFSMLLRLVLNSWTQAILPPKPPKVLGLQD* chr1(-):17359699,17359719,17362118,17362210,17373044,17373368,17377281,17377420
teRNA_172.3 - Intergenic Non-coding Non-coding chr1(-):17371039,17371059,17373044,17373368,17377281,17377420
teRNA_172.4 - Intergenic Non-coding Non-coding chr1(-):17359699,17359719,17373044,17373368,17377281,17377420
teRNA_172.5 - Intergenic Non-coding Non-coding chr1(-):17362190,17362210,17363672,17363806,17373044,17373368,17377281,17377420


GTEx

The proportion of samples in which the TE-initiated transcript was expressed across 46 body sites in the Genotype-Tissue Expression (GTEx) project.




TCGA

The proportion of samples in which the TE-initiated transcript was expressed across 33 cancer types from The Cancer Genome Atlas (TCGA).




GTEx

The expression of TE-initiated transcript across 46 body sites from The Genotype-Tissue Expression (GTEx) project.




TCGA

The expression of TE-initiated transcript across 33 cancer types from The Cancer Genome Atlas (TCGA).